92 related articles for article (PubMed ID: 8573615)
1. A human melanoma cell line transduced with an interleukin-4 gene by a retroviral vector releases biologically active IL-4 and maintains the original tumor antigenic phenotype.
Melani C; Sulé-Suso J; Arienti F; MacCalli C; Passerini F; Colombo MP; Parmiani G
Hum Gene Ther; 1995 Nov; 6(11):1427-36. PubMed ID: 8573615
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-2 gene-transduced human melanoma cells efficiently stimulate MHC-unrestricted and MHC-restricted autologous lymphocytes.
Arienti F; Sulé-Suso J; Melani C; Maccalli C; Belli F; Illeni MT; Anichini A; Cascinelli N; Colombo MP; Parmiani G
Hum Gene Ther; 1994 Sep; 5(9):1139-50. PubMed ID: 7833372
[TBL] [Abstract][Full Text] [Related]
3. Retroviral vector-mediated lymphokine gene transfer into human renal cancer cells.
Gastl G; Finstad CL; Guarini A; Bosl G; Gilboa E; Bander NH; Gansbacher B
Cancer Res; 1992 Nov; 52(22):6229-36. PubMed ID: 1423266
[TBL] [Abstract][Full Text] [Related]
4. Transfer of a TCR gene derived from a patient with a marked antitumor response conveys highly active T-cell effector functions.
Hughes MS; Yu YY; Dudley ME; Zheng Z; Robbins PF; Li Y; Wunderlich J; Hawley RG; Moayeri M; Rosenberg SA; Morgan RA
Hum Gene Ther; 2005 Apr; 16(4):457-72. PubMed ID: 15871677
[TBL] [Abstract][Full Text] [Related]
5. Suboptimal activation of CD8(+) T cells by melanoma-derived altered peptide ligands: role of Melan-A/MART-1 optimized analogues.
Carrabba MG; Castelli C; Maeurer MJ; Squarcina P; Cova A; Pilla L; Renkvist N; Parmiani G; Rivoltini L
Cancer Res; 2003 Apr; 63(7):1560-7. PubMed ID: 12670905
[TBL] [Abstract][Full Text] [Related]
6. Transduction of human melanoma cells with the gamma interferon gene enhances cellular immunity.
Abdel-Wahab ZA; Osanto S; Darrow TL; Barber JR; Vervaert CE; Gangavalli R; McCallister TJ; Seigler HF
Cancer Gene Ther; 1994 Sep; 1(3):171-9. PubMed ID: 7621248
[TBL] [Abstract][Full Text] [Related]
7. Construction and characterization of retroviral vectors expressing biologically active human interleukin-12.
Zitvogel L; Tahara H; Cai Q; Storkus WJ; Muller G; Wolf SF; Gately M; Robbins PD; Lotze MT
Hum Gene Ther; 1994 Dec; 5(12):1493-506. PubMed ID: 7711142
[TBL] [Abstract][Full Text] [Related]
8. Development and characterization of an IL-4-secreting human ovarian carcinoma cell line.
Santin AD; Ioli GR; Hiserodt JC; Rose GS; Graf MR; Tocco LM; Lander JK; Eck LM; Burger RA; DiSaia PJ
Gynecol Oncol; 1995 Aug; 58(2):230-9. PubMed ID: 7622110
[TBL] [Abstract][Full Text] [Related]
9. Selective responsiveness to common gamma chain cytokines in peripheral blood-derived cytotoxic T lymphocytes induced by Melan-A/MART-1(27-35)targeted active specific immunotherapy.
von Holzen U; Adamina M; Bolli M; Weber WP; Zajac P; Groeper C; Reschner A; Feder C; Schumacher R; Marti W; Oertli D; Heberer M; Spagnoli GC
Int J Cancer; 2005 Jun; 115(2):248-55. PubMed ID: 15688403
[TBL] [Abstract][Full Text] [Related]
10. Detection of naturally processed and HLA-A1-presented melanoma T-cell epitopes defined by CD8(+) T-cells' release of granulocyte-macrophage colony-stimulating factor but not by cytolysis.
Maeurer MJ; Martin D; Elder E; Storkus WJ; Lotze MT
Clin Cancer Res; 1996 Jan; 2(1):87-95. PubMed ID: 9816095
[TBL] [Abstract][Full Text] [Related]
11. Transduction of human melanoma cell lines with the human interleukin-7 gene using retroviral-mediated gene transfer: comparison of immunologic properties with interleukin-2.
Miller AR; McBride WH; Dubinett SM; Dougherty GJ; Thacker JD; Shau H; Kohn DB; Moen RC; Walker MJ; Chiu R
Blood; 1993 Dec; 82(12):3686-94. PubMed ID: 8260705
[TBL] [Abstract][Full Text] [Related]
12. Characterization of human tumor cell lines transduced with the cDNA encoding either tumor necrosis factor alpha (TNF-a) or interleukin-2 (IL-2).
Yannelli JR; Hyatt C; Johnson S; Hwu P; Rosenberg SA
J Immunol Methods; 1993 May; 161(1):77-90. PubMed ID: 8486931
[TBL] [Abstract][Full Text] [Related]
13. Increase of cytotoxic sensitivity of primary human melanoma cells transfected with the interleukin-7 gene to autologous and allogeneic immunologic effector cells.
Finke S; Trojaneck B; Möller P; Schadendorf D; Neubauer A; Huhn D; Schmidt-Wolf IG
Cancer Gene Ther; 1997; 4(4):260-8. PubMed ID: 9253512
[TBL] [Abstract][Full Text] [Related]
14. Novel approach to the characterization of melanoma associated-peptide-specific CTL lines from Japanese metastatic melanoma patients.
Akiyama Y; Maruyama K; Tai S; Takikawa M; Ohshita C; Yamamoto A; Yamazaki N; Kiyohara Y; Yamaguchi K
Int J Oncol; 2008 Sep; 33(3):433-41. PubMed ID: 18695871
[TBL] [Abstract][Full Text] [Related]
15. Induction of melanoma antigen-specific cytotoxic T lymphocytes in vitro by stimulation with B7-expressing human melanoma cell lines.
Fenton RG; Turcovski-Corrales SM; Taub DD
J Immunother; 1998 Mar; 21(2):95-108. PubMed ID: 9551360
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-7 gene transfer in non-small-cell lung cancer decreases tumor proliferation, modifies cell surface molecule expression, and enhances antitumor reactivity.
Sharma S; Wang J; Huang M; Paul RW; Lee P; McBride WH; Economou JS; Roth MD; Kiertscher SM; Dubinett SM
Cancer Gene Ther; 1996; 3(5):302-13. PubMed ID: 8894249
[TBL] [Abstract][Full Text] [Related]
17. Efficient transfer of a tumor antigen-reactive TCR to human peripheral blood lymphocytes confers anti-tumor reactivity.
Clay TM; Custer MC; Sachs J; Hwu P; Rosenberg SA; Nishimura MI
J Immunol; 1999 Jul; 163(1):507-13. PubMed ID: 10384155
[TBL] [Abstract][Full Text] [Related]
18. Cytokine gene transduction in tumor cells: interleukin (IL)-2 or IL-4 gene transfer in human melanoma cells.
Melani C; Chiodoni C; Arienti F; Maccalli C; Sule-Suso J; Anichini A; Colombo MP; Parmiani G
Nat Immun; 1994; 13(2-3):76-84. PubMed ID: 8173238
[TBL] [Abstract][Full Text] [Related]
19. IL-2 gene-transduced human HLA-A2 melanoma cells can generate a specific antitumor cytotoxic T-lymphocyte response.
Guarini A; Gansbacher B; Cronin K; Fierro MT; Foa R
Cytokines Mol Ther; 1995 Mar; 1(1):57-64. PubMed ID: 9384664
[TBL] [Abstract][Full Text] [Related]
20. Vaccination of melanoma patients with interleukin 4 gene-transduced allogeneic melanoma cells.
Arienti F; Belli F; Napolitano F; Sulé-Suso J; Mazzocchi A; Gallino GF; Cattelan A; Santantonio C; Rivoltini L; Melani C; Colombo MP; Cascinelli N; Maio M; Parmiani G
Hum Gene Ther; 1999 Dec; 10(18):2907-16. PubMed ID: 10609652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]